GO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Grocery Outlet Holding Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
GO Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grocery Outlet securities between November 7, 2023 and May 7, 2024, both dates inclusive (the "Class Period").

IAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Integral Ad Science Holding Corp. Stockholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
IAS Accesswire — February 19, 2025NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired IAS securities between March 2, 2023 and February 27, 2024, both dates inclusive (the "Class Period").

ICLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
ICLR Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ICON securities between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period").

VERSABANK TO HOST FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS CONFERENCE CALL/WEBCAST WEDNESDAY, MARCH 5, 2025 at 9:00 A.M. ET — Neutral
VBNK PRNewsWire — February 19, 2025Bank to Report First Quarter Fiscal 2025 Results Wednesday, March 5, 2025 at 7:00 a.m. ET LONDON, ON , Feb. 19, 2025 /PRNewswire/ - VersaBank ("VersaBank" or the "Bank") (TSX: VBNK) (NASDAQ: VBNK) will report its first quarter 2025 financial results and host a conference call to discuss those results on Wednesday, March 5, 2025.

CPRI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capri Holdings Limited Investors Have Opportunity to Lead Class Action Lawsuit! — Neutral
CPRI Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited ("Capri" or "the Company") (NYSE:CPRI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Capri securities between August 10, 2023 and October 24, 2024, both dates inclusive (the "Class Period").

CROX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Crocs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CROX Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or "the Company") (NASDAQ:CROX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Crocs securities between November 3, 2022 and October 28, 2024, both dates inclusive (the "Class Period").

IIPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Innovative Industrial Properties, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! — Neutral
IIPR Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired IIPR securities between February 27, 2024 and December 19, 2024, both dates inclusive (the "Class Period").

CRBU Shareholders Have Opportunity to Lead Caribou Biosciences, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today! — Neutral
CRBU Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. ("Caribou" or "the Company") (NASDAQ:CRBU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the "Class Period").

NXT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nextracker Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
NXT Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ: NXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Nextracker securities between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period").

PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Pacira BioSciences, Inc. to Contact the Firm Today! — Neutral
PCRX Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Pacira securities between August 2, 2023 and August 8, 2024, both dates inclusive (the "Class Period").

FTAI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that FTAI Aviation Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
FTAI Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) and certain of its officers.

enCore Energy Corp. to Attend the Prospectors and Developers Association of Canada's Convention, March 2 - 5, 2025 — Neutral
EU Newsfile Corp — February 19, 2025Dallas, Texas--(Newsfile Corp. - February 19, 2025) - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the “Company” or “enCore”), America's Clean Energy Company™, is pleased to announce its participation at the upcoming Prospectors & Developers Association of Canada's (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 2 to Wednesday, March 5, 2025. Attendees can meet with enCore Energy team members at Booth #3028 in the Investor's Exchange.

Etsy, Inc. Reports Fourth Quarter and Full Year 2024 Results — Neutral
ETSY PRNewsWire — February 19, 2025Highest-ever quarterly revenue achieved in Q4 24 BROOKLYN, N.Y. , Feb. 19, 2025 /PRNewswire/ -- Etsy, Inc. (NASDAQ: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, today announced financial results for its fourth quarter and full year ended December 31, 2024.

PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia — Neutral
PTCT PRNewsWire — February 19, 2025- PDUFA target action date of Aug. 19, 2025 - WARREN, N.J. , Feb. 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for vatiquinone for the treatment of children and adults living with Friedreich's ataxia (FA).

AZN Investors Have Opportunity to Lead AstraZeneca PLC Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today! — Neutral
AZN Accesswire — February 19, 2025NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca securities between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period").

C3 Metals Outlines 1,900 Metre by up to 650 Metre High-Grade Copper in Soil Anomaly at Khaleesi Copper-Gold Project, Peru — Neutral
CUAUF FCX Newsfile Corp — February 19, 2025Toronto, Ontario--(Newsfile Corp. - February 19, 2025) - C3 Metals Inc. (TSXV: CCCM) (OTCQB: CUAUF) ("C3 Metals" or the "Company") is pleased to announce results of a highly successful grid-based soil sampling campaign over the Khaleesi Copper-Gold project area in Southern Peru. Previous mapping and rock sampling identified an alteration footprint spanning 1,500m by 1,000m.

Cyngn Deploys Autonomous DriveMod Vehicles Across Multiple Industries — Neutral
CYN PRNewsWire — February 19, 2025Deployments of Cyngn's DriveMod Tugger and Forklift have now included four key sectors: Manufacturing, Consumer Packaged Goods, Logistics, and Defense Use cases are diverse and highlight adaptability, scalability, and different value propositions of Cyngn's solutions. Reflects market demand to adopt industrial automation across Cyngn's broadening customer base.

Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025 — Neutral
ONCY PRNewsWire — February 19, 2025Regulatory progress in pancreatic cancer and recent clinical data presentations in two hard-to-treat GI cancers, coupled with strong efficacy signals in breast cancer, highlight pelareorep's potential impact across a range of tumors //Republication of press release issued February 18 th 2025 due to news transmission coverage// SAN DIEGO and CALGARY, AB , Feb. 19, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep's potential in hard-to-treat cancers. Oncolytics is pleased to highlight two significant developments …

Mastech Digital Reports Consolidated Fourth Quarter Revenue Growth of 10.2% — Neutral
MHH PRNewsWire — February 19, 2025The Company's Data and Analytics Services Segment achieved 26.2% Revenue Growth during Quarter PITTSBURGH , Feb. 19, 2025 /PRNewswire/ -- Mastech Digital, Inc. (NYSE American: MHH), a leading provider of Digital Transformation IT Services, announced today its financial results for the fourth quarter and full year ended December 31, 2024. Additionally, Mastech Digital announced that its Board of Directors authorized an extension of the previously announced share repurchase program for an additional year through February 8, 2026.

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference — Neutral
CALC PRNewsWire — February 19, 2025LA JOLLA, Calif. , Feb. 19, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference (AKI & CRRT) being held March 3-6, 2025 in San Diego, CA.
